If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
3
Followers on Owler
Sequella
is a antiinfectives company focused on discovering and developing treatments for serious infectious diseases...
Read more
Overview
Competitors
Funding
News & Insights
Sequella
is a antiinfectives company focused on discovering and developing treatments for serious infectious diseases...
Read more
Co-Founder & CEO
Carol A. Nacy
CEO Approval Rating
69/100
Weigh In
1997
Rockville
Maryland
Washington Metropolitan Area
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://sequella.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$11.9M
News
Latest News
Oct 29, 2018
BioPortfolio
Sequella: Sequella Inc Medical Equipment Deals and Alliances Profile Report Updated 15102018 Prices from USD $250
Oct 25, 2018
BioPortfolio
Sequella: Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11102018 Prices from USD $250
Sep 06, 2018
BioPortfolio
Sequella: Sequella Inc Medical Equipment Deals and Alliances Profile Report Updated 12062018 Prices from USD $250
May 24, 2018
24-7 Press Release Newswire
Press Release: Sequella : Sequella Incorporated Gets Listed on THE OCMX
Nov 22, 2017
BioPortfolio
Sequella: Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14112017 Prices from USD $250
Sep 04, 2017
BioPortfolio
Sequella: Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
Jul 31, 2017
BioPortfolio
Sequella: Sequella Inc Medical Equipment Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
May 25, 2017
BioPortfolio
Sequella: Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 16052017 Prices from USD $250
Mar 27, 2017
Blackbird
Press Release: Sequella : Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis
Mar 25, 2017
BioPortfolio
Sequella: Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250
Follow and Get Alerts
Sequella Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies